China Isotope & Radiation Corporation (HKG:1763)

Market Cap	3.68B
Revenue (ttm)	8.06B
Net Income (ttm)	432.74M
Shares Out	319.87M
EPS (ttm)	1.35
PE Ratio	8.50
Forward PE	n/a
Dividend	0.40 (3.50%)
Ex-Dividend Date	Jun 5, 2025

Volume	343,400
Average Volume	309,810
Open	11.56
Previous Close	11.56
Day's Range	11.38 - 11.66
52-Week Range	9.30 - 13.78
Beta	0.74
RSI	47.21
Earnings Date	Mar 27, 2025

About China Isotope & Radiation

China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Other Businesses. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; ur...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1983
• Employees: 3,367
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1763

Financial Performance

In 2024, China Isotope & Radiation's revenue was 7.57 billion, an increase of 14.16% compared to the previous year's 6.63 billion. Earnings were 406.65 million, an increase of 9.62%.

Financial numbers in CNY